P2Y Receptors Activate MAPK/ERK Through a Pathway Involving PI3K/PDK1/PKC-ζ in Human Vein Endothelial Cells

Motte S, 1995, Int J Biochem Cell Biol, 27, 1, 10.1016/1357-2725(94)00059-X

Ralevic V, 1998, Pharmacol Rev, 50, 413, 10.1016/S0031-6997(24)01373-5

Communi D, 2000, Cell Signal, 12, 351, 10.1016/S0898-6568(00)00083-8

Vassort G, 2001, Physiol Rev, 81, 767, 10.1152/physrev.2001.81.2.767

Wang L, 2002, J Cardiovasc Pharmacol, 40, 841, 10.1097/00005344-200212000-00005

Kunapuli SP, 1998, Biochem J, 336, 513, 10.1042/bj3360513

Patel V, 1996, Biochem J, 320, 221, 10.1042/bj3200221

Brown CA, 1996, Biochem Pharmacol, 52, 1849, 10.1016/S0006-2952(96)00550-3

10.1161/01.CIR.0000066912.58385.DE

10.1002/jcp.10333

10.1161/hq0302.105360

Tanaka N, 2004, J Pharmacol Sci, 95, 174, 10.1254/jphs.FPJ03036X

Kaczmarek E, 2005, Thromb Haemost, 93, 735, 10.1160/TH04-09-0576

Graham A, 1996, Biochem J, 315, 563, 10.1042/bj3150563

Albert JL, 1997, Br J Pharmacol, 122, 935, 10.1038/sj.bjp.0701453

Jaffe EA, 1973, J Clin Invest, 52, 2745, 10.1172/JCI107470

10.1006/abio.1976.9999

Parker PJ, 1995, Biochem Soc Trans, 23, 153, 10.1042/bst0230153

Martiny-Baron G, 1993, J Biol Chem, 268, 9194, 10.1016/S0021-9258(18)98335-3

Nicholas RA, 1996, J Auton Pharmacol, 16, 319, 10.1111/j.1474-8673.1996.tb00044.x

Boarder MR, 1998, Trends Pharmacol Sci, 19, 99, 10.1016/S0165-6147(98)01170-5

King BF, 1998, Trends Pharmacol Sci, 19, 506, 10.1016/S0165-6147(98)01271-1

Elia MG, 2005, Cell Signal, 17, 739, 10.1016/j.cellsig.2004.10.013

Short SM, 2000, J Biol Chem, 275, 12970, 10.1074/jbc.275.17.12970

10.1038/364249a0

Blaukat A, 1999, J Biol Chem, 274, 14893, 10.1074/jbc.274.21.14893

Agell N, 2002, Cell Signal, 14, 649, 10.1016/S0898-6568(02)00007-4

Jimenez E, 2005, J Cell Physiol, 204, 678, 10.1002/jcp.20326

10.1002/jcp.10242

0 Murga C, Laguinge L, Wetzker R, Cuadrado A, Gutkind JS: Activation of Akt/protein kinase B by G proteincoupled receptors. A role for alpha and betagamma subunits of heterotrimeric G proteins acting through phosphatidylinositol-3-OH kinase gamma.J Biol Chem 1998;273:19080-19085.

10.1042/BJ20021626

10.1038/sj.bjp.0704748

3 Van Kolen K, Gilany K, Moens L, Esmans EL, Slegers H: P2Y12receptor signalling towards PKB proceeds through IGF-I receptor cross-talk and requires activation of Src, Pyk2 and Rap1. Cell Signal 2005. (in press).

Yang J, 2002, Mol Cell, 9, 1227, 10.1016/S1097-2765(02)00550-6

Casamayor A, 1999, Biochem J, 342, 287, 10.1042/bj3420287

Stokoe D, 1997, Science, 277, 567, 10.1126/science.277.5325.567

Le Good JA, 1998, Science, 281, 2042, 10.1126/science.281.5385.2042

Balendran A, 2000, J Biol Chem, 275, 20806, 10.1074/jbc.M000421200

10.1016/S0955-0674(99)80023-4

Liebmann C, 2000, Curr Med Chem, 7, 911, 10.2174/0929867003374589

10.1016/S0092-8674(00)00086-6

Lopez-Ilasaca M, 1997, Science, 275, 394, 10.1126/science.275.5298.394

Rubio I, 1997, Biochem J, 326, 891, 10.1042/bj3260891

Cuevas B, 2005, J Biol Chem, 274, 27583, 10.1074/jbc.274.39.27583

Moon KD, 2005, J Biol Chem, 280, 1543, 10.1074/jbc.M407805200

Santiago-Perez LI, 2001, J Cell Physiol, 187, 196, 10.1002/jcp.1063

Porfiri E, 1994, J Biol Chem, 269, 22672, 10.1016/S0021-9258(17)31698-8